Showing results (331-340 of 390) with videos related to
Sort By:
Pageof 39
The Lancet. Infectious Diseases|September 28, 2019
Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trialDora Buonfrate, Joaquin Salas-Coronas, José Muñoz, et al.Medicine|July 22, 2016
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort studyEmanuele Focà, Massimiliano Fabbiani, Mattia Prosperi, et al.Plos One|October 13, 2021
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohortEmanuele Focà, Andrea Calcagno, Stefano Calza, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 22, 2015
West Nile virus outbreak in the Lombardy region, northern Italy, summer 2013Francesca Rovida, Antonella Sarasini, Giulia Campanini, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) studyLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.Annals of Neurology|May 18, 2020
Steroid-Responsive Encephalitis in Coronavirus Disease 2019Andrea Pilotto, Silvia Odolini, Stefano Masciocchi, et al.Le Infezioni in Medicina|June 1, 2021
Valacyclovir for prevention and treatment of fetal CMV infection: inclusion in the Law 648/96 list and launch of the Italian multicentre observational prospective study "MEGAL-ITALI"Lorenzo Zammarchi, Tiziana Lazzarotto, Mariarosaria Di Tommaso, et al.The Lancet. HIV|February 25, 2018
Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trialAlan Winston, Frank A Post, Edwin DeJesus, et al.Clinical and Experimental Gastroenterology|December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infectionChristoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2024
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 TrialOnyema Ogbuagu, Jean-Michel Molina, Ploenchan Chetchotisakd, et al.Pageof 39